Recombinant interferon alpha2 (IFNalpha2) mutants

Details for Australian Patent Application No. 2006263331 (hide)

Owner Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science

Inventors Kalie, Eyal; Jaitin, Diego; Schreiber, Gideon; Roisman, Laila C.

Agent Freehills

Pub. Number AU-B-2006263331

PCT Pub. Number WO2007/000769

Priority 60/694,810 29.06.05 US

Filing date 28 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 16 February 2012

International Classifications

C07K 14/57 (2006.01) Peptides having more than 20 amino acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/000769 Priority application(s): WO2007/000769

16 February 2012 Application Accepted

  Published as AU-B-2006263331

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006263332-Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes

2006263329-Safe inspection system and kit